HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

J A Staessen Selected Research

Nitrendipine

12/2004Blood pressure and dementia.
7/2003[Syst-Eur study: analysis of the benefits of nitrendipine in hypertensive type 2 diabetics].
12/2001Dihydropyridine calcium-channel blockers for antihypertensive treatment in older patients--evidence from the Systolic Hypertension in Europe Trial.
11/2001Risk and benefit of treatment of isolated systolic hypertension in the elderly: evidence from the Systolic Hypertension in Europe Trial.
3/2001Follow-up of renal function in treated and untreated older patients with isolated systolic hypertension. Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.
10/2000Cerebral complications of hypertension.
7/2000[Cognitive impairment and dementia in hypertension; the effect of antihypertensive medication].
1/2000Chinese trial on isolated systolic hypertension in the elderly. Systolic Hypertension in China (Syst-China) Collaborative Group.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


J A Staessen Research Topics

Disease

15Hypertension (High Blood Pressure)
12/2013 - 02/2000
14Isolated Systolic Hypertension
07/2003 - 01/2000
12Stroke (Strokes)
01/2011 - 01/2000
5Dementia (Dementias)
12/2004 - 07/2000
4Diabetes Mellitus
11/2004 - 02/2000
3Cardiovascular Diseases (Cardiovascular Disease)
07/2003 - 12/2000
2Alzheimer Disease (Alzheimer's Disease)
12/2004 - 10/2000
2Proteinuria
12/2001 - 03/2001
2Myocardial Infarction
10/2001 - 03/2001
2Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
12/2000 - 07/2000
1Essential Hypertension
11/2012
1Inflammation (Inflammations)
01/2008
1Hemorrhage
09/2001
1Neoplasms (Cancer)
02/2001
1Coronary Disease (Coronary Heart Disease)
12/2000
1White Coat Hypertension
08/2000
1Cognitive Dysfunction
07/2000

Drug/Important Bio-Agent (IBA)

16Antihypertensive Agents (Antihypertensives)IBA
12/2013 - 01/2000
11Calcium Channel Blockers (Blockers, Calcium Channel)IBA
12/2001 - 01/2000
8NitrendipineIBA
12/2004 - 01/2000
51,4-dihydropyridine (dihydropyridine)IBA
12/2004 - 01/2000
3Pharmaceutical PreparationsIBA
01/2011 - 03/2000
3Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
12/2001 - 07/2000
3CreatinineIBA
12/2001 - 03/2001
2adducinIBA
05/2007 - 12/2001
2Proteins (Proteins, Gene)FDA Link
05/2007 - 12/2001
2AngiotensinogenIBA
02/2005 - 12/2000
2CalciumIBA
12/2004 - 07/2000
2antineoplaston A10 (A 10)IBA
04/2004 - 03/2000
1SaltsIBA
11/2012
14- (2- (4- hydroxybenzyl)- phenoxy)- N- methylbutylamineIBA
12/2010
1Biological ProductsIBA
01/2008
1CationsIBA
05/2007
1AlbuminsIBA
11/2004
1HDL CholesterolIBA
04/2004
1N 556IBA
12/2001
1Cytochrome P-450 CYP11B2 (CYP11B2)IBA
12/2001
1Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
10/2001
1Enzyme Inhibitors (Inhibitors, Enzyme)IBA
10/2001
1Diltiazem (Cardizem)FDA LinkGeneric
10/2001
1Captopril (Capoten)FDA LinkGeneric
10/2001
1Doxazosin (Cardura)FDA LinkGeneric
10/2001
1DiureticsIBA
10/2001
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
09/2001
1ReninIBA
08/2001
1AldosteroneIBA
08/2001
1Oxygen (Dioxygen)IBA
07/2001
1ThiazidesIBA
04/2001
1Uric Acid (Urate)IBA
04/2001
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
03/2001
1Type 1 Angiotensin ReceptorIBA
12/2000
1EnalaprilFDA LinkGeneric
10/2000
1N-9-fluorenylacetyl-L-phenylalanine (A 192)IBA
07/2000
1CadmiumIBA
02/2000

Therapy/Procedure

1Secondary Prevention
09/2001
1Therapeutics
09/2000